RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Ryan M. Carr(Novel (United States)), Mrinal M. Patnaik(Mayo Clinic)
Cited by 97
Related Papers
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease
|Haematologica|2019|215
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
|American Journal of Hematology|2020|136
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis
|Bone Marrow Transplantation|2018|46
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
|Biology of Blood and Marrow Transplantation|2018|34